HUP0401899A2 - Eljárás ribavirin előállítására - Google Patents
Eljárás ribavirin előállításáraInfo
- Publication number
- HUP0401899A2 HUP0401899A2 HU0401899A HUP0401899A HUP0401899A2 HU P0401899 A2 HUP0401899 A2 HU P0401899A2 HU 0401899 A HU0401899 A HU 0401899A HU P0401899 A HUP0401899 A HU P0401899A HU P0401899 A2 HUP0401899 A2 HU P0401899A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- formula
- ribavirin
- general formula
- carbon
- Prior art date
Links
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title abstract 3
- 229960000329 ribavirin Drugs 0.000 title abstract 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 abstract 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- OXNGKCPRVRBHPO-XLMUYGLTSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O OXNGKCPRVRBHPO-XLMUYGLTSA-N 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- YDVJBLJCSLVMSY-UHFFFAOYSA-N carbamoyl cyanide Chemical group NC(=O)C#N YDVJBLJCSLVMSY-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 150000003852 triazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány tárgya eljárás (R) képletű ribavirin előállítására olymódon, hogy a) egy (I) általános képletű triazolt - a képletben R2jelentése 1-4 szénatomos alkoxikarbonil-, arilalkoxikarbonil-,karboxil-, ciano-, karboxiamidcsoport - egy (II) általános képletűvédett ribofuranózzal reagáltatnak - a képletben Pg jelentésehidroxil-védőcsoport és R1 jelentése lehasadócsoport, amely 1-4szénatomos aciloxi-, ariloxicsoport vagy halogénatom - oldószer ésLewis-sav jelenlétében, és b) a kapott (III) általános képletűvegyületről - a képletben Pg és R2 jelentése a fenti - a Pgcsoportokat eltávolítják és az R2 csoportot karboxiamidcsoporttáalakítják, így nyerik a ribavirint. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01830510A EP1281715B1 (en) | 2001-07-30 | 2001-07-30 | Process for the preparation of ribavirin |
| PCT/IB2002/002950 WO2003011884A1 (en) | 2001-07-30 | 2002-07-29 | Process for the preparation of ribavirin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401899A2 true HUP0401899A2 (hu) | 2004-12-28 |
Family
ID=8184638
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401615A HUP0401615A2 (hu) | 2001-07-30 | 2002-07-25 | Eljárás L-ribavirin előállítására |
| HU0401899A HUP0401899A2 (hu) | 2001-07-30 | 2002-07-29 | Eljárás ribavirin előállítására |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401615A HUP0401615A2 (hu) | 2001-07-30 | 2002-07-25 | Eljárás L-ribavirin előállítására |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7285660B2 (hu) |
| EP (2) | EP1281715B1 (hu) |
| JP (2) | JP2004538317A (hu) |
| KR (2) | KR20040031784A (hu) |
| CN (2) | CN1255420C (hu) |
| AT (2) | ATE252594T1 (hu) |
| AU (1) | AU2002328974A1 (hu) |
| BR (2) | BR0210278A (hu) |
| DE (2) | DE60101056T2 (hu) |
| ES (2) | ES2208540T3 (hu) |
| HU (2) | HUP0401615A2 (hu) |
| MX (2) | MXPA04000382A (hu) |
| WO (2) | WO2003011883A2 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005539032A (ja) * | 2002-08-12 | 2005-12-22 | エフ．ホフマン−ラ ロシュ アーゲー | リボフラノースの製造方法 |
| WO2007007183A2 (en) * | 2005-07-08 | 2007-01-18 | Aurobindo Pharma Limited | Compositions of antiviral compound |
| JP2008222630A (ja) * | 2007-03-12 | 2008-09-25 | Permachem Asia Ltd | １−β−Ｄ−リボフラノシルー１，２，４−トリアゾール−３−カルボキサミドのＲ−ＩＩ型結晶の製造法 |
| CN101891786B (zh) * | 2010-08-04 | 2012-09-05 | 王明 | 一种利巴韦林化合物及其制法 |
| TW201242974A (en) | 2010-11-30 | 2012-11-01 | Gilead Pharmasset Llc | Compounds |
| CN102127134B (zh) * | 2010-12-02 | 2012-11-14 | 海南美兰史克制药有限公司 | 一种利巴韦林化合物及其方法 |
| CN102532226B (zh) * | 2010-12-15 | 2014-05-07 | 上海迪赛诺医药发展有限公司 | 利巴韦林晶型及其制备方法 |
| CN109134565A (zh) * | 2017-08-15 | 2019-01-04 | 李双喜 | 一种1/10水利巴韦林化合物及其药物组合物 |
| CN109134566A (zh) * | 2017-08-18 | 2019-01-04 | 樊艳芳 | 一种1/20水利巴韦林化合物 |
| CN108484691A (zh) * | 2018-06-28 | 2018-09-04 | 牡丹江师范学院 | 一种利巴韦林缩合物的化学合成方法 |
| CN111647033A (zh) * | 2020-06-08 | 2020-09-11 | 济南明鑫制药股份有限公司 | 一锅法制备利巴韦林的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
| JPS55160793A (en) * | 1979-05-29 | 1980-12-13 | Microbial Chem Res Found | Preparation of virazole |
| JPS5931797A (ja) * | 1982-08-18 | 1984-02-20 | Sumitomo Chem Co Ltd | 新規１−置換イミダゾ−ルヌクレオシドおよびその製造法 |
| JPS60252493A (ja) * | 1984-05-25 | 1985-12-13 | Takeda Chem Ind Ltd | シチジン誘導体の製造法 |
| KR880011146A (ko) * | 1987-03-25 | 1988-10-26 | 엠.피.젝슨 | 3'-아지도-3'-디옥시티미딘의 신규 제조방법 및 이러한 공정에 유용한 중간체 |
| CN1049435C (zh) * | 1994-11-09 | 2000-02-16 | 中国科学院上海药物研究所 | 含苯基和杂环基的青蒿素衍生物及其制备方法 |
| EP1254911A1 (en) * | 1996-10-16 | 2002-11-06 | ICN Pharmaceuticals, Inc. | Monocyclic L-nucleosides, analogs and uses thereof |
| IL129126A0 (en) * | 1996-10-16 | 2000-02-17 | Icn Pharmaceuticals | Monocyclic l-nucleosides analogs and uses thereof |
-
2001
- 2001-07-30 DE DE60101056T patent/DE60101056T2/de not_active Expired - Lifetime
- 2001-07-30 EP EP01830510A patent/EP1281715B1/en not_active Expired - Lifetime
- 2001-07-30 ES ES01830510T patent/ES2208540T3/es not_active Expired - Lifetime
- 2001-07-30 AT AT01830510T patent/ATE252594T1/de not_active IP Right Cessation
-
2002
- 2002-07-25 MX MXPA04000382A patent/MXPA04000382A/es active IP Right Grant
- 2002-07-25 EP EP02764788A patent/EP1414836B1/en not_active Expired - Lifetime
- 2002-07-25 JP JP2003517074A patent/JP2004538317A/ja active Pending
- 2002-07-25 DE DE60202483T patent/DE60202483T2/de not_active Expired - Fee Related
- 2002-07-25 AU AU2002328974A patent/AU2002328974A1/en not_active Abandoned
- 2002-07-25 KR KR10-2004-7001404A patent/KR20040031784A/ko not_active Application Discontinuation
- 2002-07-25 US US10/485,436 patent/US7285660B2/en not_active Expired - Fee Related
- 2002-07-25 ES ES02764788T patent/ES2233857T3/es not_active Expired - Lifetime
- 2002-07-25 AT AT02764788T patent/ATE286062T1/de not_active IP Right Cessation
- 2002-07-25 WO PCT/EP2002/008330 patent/WO2003011883A2/en active IP Right Grant
- 2002-07-25 HU HU0401615A patent/HUP0401615A2/hu unknown
- 2002-07-25 CN CNB028149246A patent/CN1255420C/zh not_active Expired - Fee Related
- 2002-07-25 BR BR0210278-1A patent/BR0210278A/pt not_active IP Right Cessation
- 2002-07-29 BR BR0209815-6A patent/BR0209815A/pt not_active IP Right Cessation
- 2002-07-29 JP JP2003517075A patent/JP2004538318A/ja active Pending
- 2002-07-29 CN CNB028149254A patent/CN1255421C/zh not_active Expired - Fee Related
- 2002-07-29 MX MXPA03010251A patent/MXPA03010251A/es active IP Right Grant
- 2002-07-29 HU HU0401899A patent/HUP0401899A2/hu unknown
- 2002-07-29 KR KR1020047001334A patent/KR100953031B1/ko not_active IP Right Cessation
- 2002-07-29 WO PCT/IB2002/002950 patent/WO2003011884A1/en active Application Filing
- 2002-07-29 US US10/485,335 patent/US7285659B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401899A2 (hu) | Eljárás ribavirin előállítására | |
| BR9907936A (pt) | Composição farmacêutica, composto, e, processo para preparar o mesmo | |
| BR0215308A (pt) | Pirrolopirimidinas | |
| CY1108931T1 (el) | Μεθοδος παρασκευης παραγωγων βενζιμιδαζολ-2-υλο-κινολινονης | |
| EP1306377A3 (en) | Pyridyl-oxazoles and their use as cytokines inhibitors | |
| BR0311343A (pt) | Derivados de piridazina | |
| ATE348814T1 (de) | Verfahren zur herstellung von chinolinderivaten | |
| WO2002076976A3 (en) | Rho-kinase inhibitors | |
| HUP0302755A2 (hu) | Eljárás kamptotecin-analóg vegyületek előállítására | |
| HUP0303166A2 (hu) | Eljárás 2-(6-helyettesített 1,3-dioxán-4-il)-ecetsav-származékok előállítására | |
| MY142915A (en) | Rho-kinase inhibitors | |
| HUP9900006A2 (hu) | Ciklikus GMP-specifikus foszfo-diészteráz inhibitor vegyületek, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| TR200200137T2 (tr) | Nükleotid analog kompozisyonlar. | |
| HUP0301817A2 (hu) | Kahalalid-vegyületek, elżállításukra szolgáló eljárás, azokat tartalmazó gyógyászati készítmények és alkalmazásuk | |
| HUP0400091A2 (hu) | Eljárás antidiabetikus hatású pioglitazon előállítására | |
| BR0213683A (pt) | Hidrazono-malonitrilas | |
| CA2070551A1 (en) | Polymerization inhibitors for acrylic acids and esters | |
| MY141871A (en) | A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | |
| HUP0100743A2 (hu) | Eljárás szimvasztatin és származékai előállítására | |
| HUP0003273A2 (hu) | Eljárás izoxazolidin-dion-származékok előállítására | |
| DE69911430D1 (de) | Verfahren zur herstellung von 1-(1h)-benzoquinolizin-3-on derivaten | |
| Palla et al. | DNA sequencing by synthesis using 3′-O-azidomethyl nucleotide reversible terminators and surface-enhanced Raman spectroscopic detection | |
| WO2000031299A3 (en) | Method for determining nucleotide sequences using arbitrary primers and low stringency | |
| WO2008101448A4 (en) | Method of manufacturing 1-(2-deoxy-alpha-d-erythro-pentofuranosyl)-5-azacytosine | |
| HUP0100740A2 (hu) | Eljárás szubsztituált benzoil-cianid-amidinohidrazonok előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |